DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of “Hold” from Analysts

by · The Cerbat Gem

DocGo Inc. (NASDAQ:DCGO – Get Free Report) has received an average recommendation of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $3.2125.

Several brokerages have recently commented on DCGO. Canaccord Genuity Group cut their price target on DocGo from $1.60 to $1.50 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Zacks Research raised shares of DocGo from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of DocGo in a research report on Monday, December 15th.

Check Out Our Latest Analysis on DocGo

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. CWM LLC lifted its stake in shares of DocGo by 2,613.3% during the 2nd quarter. CWM LLC now owns 21,978 shares of the company’s stock worth $35,000 after purchasing an additional 21,168 shares during the last quarter. Cerity Partners LLC purchased a new stake in shares of DocGo during the second quarter valued at about $37,000. Strs Ohio purchased a new stake in shares of DocGo during the first quarter valued at about $76,000. Engineers Gate Manager LP bought a new stake in shares of DocGo in the 2nd quarter valued at about $52,000. Finally, Royce & Associates LP purchased a new position in shares of DocGo in the 3rd quarter worth approximately $64,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Stock Performance

DocGo stock opened at $0.89 on Thursday. The company has a market capitalization of $86.69 million, a PE ratio of -1.70 and a beta of 0.93. The company has a 50 day moving average price of $1.02 and a 200-day moving average price of $1.32. DocGo has a fifty-two week low of $0.86 and a fifty-two week high of $5.68.

DocGo (NASDAQ:DCGO – Get Free Report) last announced its quarterly earnings data on Monday, November 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.02). The firm had revenue of $70.81 million during the quarter, compared to the consensus estimate of $69.96 million. DocGo had a negative return on equity of 9.11% and a negative net margin of 14.02%. On average, analysts forecast that DocGo will post 0.25 earnings per share for the current year.

DocGo Company Profile

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Further Reading